SSKN
STRATA Skin Sciences, Inc.NASDAQHealthcare$0.19-2.63%ClosedMarket Cap: $883,539
As of 2026-04-04
Valuation
P/E (TTM)
—
PEG
—
P/B
0.37
P/S
0.03
EV/EBITDA
-16.34
DCF Value
$-1.09
FCF Yield
-495.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
57.8%
Operating Margin
-19.7%
Net Margin
-21.1%
ROE
-360.3%
ROA
-21.2%
ROIC
-31.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $9.3M | 60.4% | $37.0K | $58.0K | $0.01 | — |
| FY 2025 | $30.7M | 58.3% | $-5.8M | $-6.3M | $-1.35 | — |
| Q3 2025 | $6.9M | 60.4% | $-1.9M | $-1.6M | $-0.36 | — |
| Q2 2025 | $7.7M | 56.2% | $-2.2M | $-2.5M | $-0.60 | — |
| Q1 2025 | $6.8M | 53.5% | $-2.0M | $-2.4M | $-0.06 | — |
| Q4 2024 | $9.6M | 60.1% | $-4.2M | $-4.5M | $-0.12 | — |
| FY 2024 | $33.6M | 56.9% | $-9.3M | $-10.1M | $-0.26 | — |
| Q3 2024 | $8.8M | 60.3% | $-1.7M | $-2.1M | $-0.05 | — |
| Q2 2024 | $8.4M | 58.5% | $-486.0K | $-99.0K | $-0.00 | — |
| Q1 2024 | $6.8M | 45.6% | $-2.9M | $-3.4M | $-0.10 | — |
| Q4 2023 | $8.7M | 55.3% | $-3.4M | $-3.8M | $-0.11 | — |
| FY 2023 | $33.4M | 55.3% | $-8.6M | $-10.8M | $-0.31 | — |